Organosulfur compounds for the prevention and treatment of neurodegenerative diseases
US10118891B2 · kind B2 · utility
0Cited by
3References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 1, 2017 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Mar 1, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Organosulfur compounds and compositions are disclosed which can be administered in order to provide protection from the formation of aldehyde-protein adducts, protein aggregates, and the resulting neuroinflammation. Various neurodegenerative diseases which are suitable for treatment using these compositions include Alzheimer's disease, senile dementia, Parkinson's disease, multiple sclerosis, Lewy body disease, peripheral neuropathy, spinal cord injury, traumatic brain injury, stroke and cerebral ischemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.